Key facts
- This page summarizes Jun Yoon's Form 4 filing for Structure Therapeutics Inc. (GPCR).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2025, 20:45.
Jun Yoon - 15 Mar 2025 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- GPCR
- Reported as of
- 15 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 20:45:07 UTC
- Prior SEC filing
- 03 Jul 2025
- Next SEC filing
- 05 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jun Yoon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jun Yoon filed Form 4 for Structure Therapeutics Inc. (GPCR) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 03 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GPCR
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +170,166
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 1,293,299
- Date
- 15 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
GPCR
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,554,586
- Date
- 15 Mar 2025
- Ownership
- See footnote
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GPCR
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +413,445
- Change %
- Price
- $0.000000
- Shares after
- 413,445
- Date
- 15 Mar 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 413,445
- Exercise price
- $7.02
- Footnotes
- F1, F4, F5
GPCR
transaction
Derivative
American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +694
- Change %
- +116%
- Price
- $0.000000
- Shares after
- 1,294
- Date
- 20 May 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,082
- Exercise price
- Footnotes
- F1, F6, F7
GPCR
transaction
Derivative
American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +821
- Change %
- +63%
- Price
- $0.000000
- Shares after
- 2,115
- Date
- 20 Nov 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,463
- Exercise price
- Footnotes
- F1, F6, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
Footnote F2
Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
Footnote F3
By Jun Sik Yoon and Hayung Yang Yoon, Trustees of The Yoon Family Trust, dated December 11, 2019.
Footnote F4
The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
Footnote F5
1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
Footnote F6
Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
Footnote F7
Voluntary reporting of the acquisition of 694 ADSs by the Reporting Person on May 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.
Footnote F8
Voluntary reporting of the acquisition of 821 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.